We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MICC:NYSEThe Magnum Ice Cream Company N.V. Analysis

Data as of 2026-04-17 - not real-time

$14.15

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical indicators suggest a mixed picture. The price is trading below its 20‑day and 50‑day moving averages, the RSI sits in oversold territory and the MACD histogram has just turned positive, hinting at a possible short‑term bounce. However, volume is on a decreasing trend and the broader trend remains bearish, with the stock hovering just above a key support level.
Fundamentally, the spin‑off status provides a clear strategic focus but the valuation appears stretched. A DCF fair‑value estimate is far below the current market price, while the price‑to‑earnings and price‑to‑book multiples are markedly high for a consumer‑defensive business. The company shows modest profitability, low leverage relative to its equity base, and solid cash flow generation, yet earnings growth has stalled and analysts have issued a neutral “hold” rating. Recent earnings disappointment and litigation concerns add short‑term headwinds, but the brand portfolio and potential margin expansion remain attractive over a longer horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with bearish trend
  • Oversold RSI suggesting limited downside
  • Recent earnings miss and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential margin expansion from focused spin‑off operations
  • High valuation relative to fair‑value estimate
  • Improving cash flow but modest earnings growth

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong brand portfolio in a defensive consumer segment
  • Continued valuation premium versus fundamentals
  • Exposure to global currency and regulatory environments

Key Metrics & Analysis

Financial Health

Revenue Growth-4.10%
Profit Margin3.70%
P/E Ratio24.8
ROE17.88%
ROA8.72%
Debt/Equity539.65
P/B Ratio12.0
Op. Cash Flow$483.0M
Free Cash Flow$365.6M

Technical Analysis

TrendBearish
RSI37.1
Support$13.96
Resistance$15.40
MA 20$14.55
MA 50$15.67
MA 200$15.87
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39

Valuation

Fair Value$3.22
Target Price$17.80
Upside/Downside25.80%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.62
Volatility20.68%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.